Crossmark

Health Technology Assessment Guidelines and Recommendations Across European Union Countries and the United Kingdom in Rare Disease and Paediatric Populations

Crossref DOI link: https://doi.org/10.1007/s40258-025-01008-0

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bártová, Adéla https://orcid.org/0000-0002-1619-217X
Samek, Jiří

Pinheiro, Vera

Říhová, Barbora

Santos, João Vasco
Funding

Funding for this research was provided by:

MSMT (Specific University Research (MUNI/A/1722/2024))

HORIZON EUROPE Coordination and Support Action (Grant agreement number 101059788)

Masaryk University
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 25 March 2025

Accepted: 23 September 2025

First Online: 16 October 2025

Declarations

:

: The authors declare that they have no financial or nonfinancial interests in the work submitted for publication, whether directly or indirectly associated.

: All data supporting the findings of this study are included in the manuscript and its supplementary materials (Supplementary File 1 and Supplementary File 2).

: All the authors contributed to the study's conception and design. AB prepared the materials, collected the data, and conducted the analyses. AB wrote the initial draft of the manuscript. VP contributed to the Discussion section. All the authors interpreted the results, revised the draft critically and approved the final article.

: Not applicable.

: Not applicable.

: Not applicable.

: No custom code was generated or used in this study.

Document is current

Any future updates will be listed below